Stockreport

Alzheimer's Clinical Trial Results, Sadly Running True To Form [Seeking Alpha]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF Novo Nordisk (NVO) recently reported that semaglutide (the company's GLP-1 agonist drug) failed in two Alzheimer's trials. Studies of thousands of patients with early c [Read more]